Mometasone + Formoterol Suppliers & Bulk Manufacturers

Available Forms: Inhaler(MDI)

Available Strengths: 100 mcg/5 mcg , 200 mcg/5 mcg

Reference Brands: Dulera®(US)

Category: Respiratory Disorder

Mometasone + Formoterol, sold as Dulera® in the U.S., is a combination inhaler for asthma management. It pairs Mometasone furoate (ICS) with Formoterol fumarate (LABA) to reduce inflammation and improve airflow. Available as a metered-dose inhaler in 100/5 mcg and 200/5 mcg strengths, Dulera® offers effective, long-term asthma control. Mometasone + Formoterol is available in Inhaler(MDI) and strengths such as 100 mcg/5 mcg , 200 mcg/5 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Mometasone + Formoterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Mometasone + Formoterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Mometasone + Formoterol, marketed as Dulera® in the United States, is a combination inhaler used to manage asthma in patients aged 12 years and older. It combines Mometasone furoate, an inhaled corticosteroid (ICS) that reduces airway inflammation, with Formoterol fumarate, a long-acting beta-agonist (LABA) that relaxes bronchial muscles for easier breathing. This powerful duo helps control asthma symptoms and prevent attacks. Dulera® is available in metered-dose inhaler (MDI) form in two strengths: 100 mcg/5 mcg and 200 mcg/5 mcg. Widely prescribed in the U.S., it is a key component in respiratory therapy and pharma B2B exports.